"Rounding Third Base and Heading Home": Arthritis & Rheumatology in 2024

Affiliations

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
³ Yale School of Medicine, New Haven, Connecticut.

Editorial

Daniel H Solomon et al. Arthritis Rheumatol. 2024 Jun.

. 2024 Jun;76(6):819-822.

doi: 10.1002/art.42828. Epub 2024 Apr 4.

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
³ Yale School of Medicine, New Haven, Connecticut.

No abstract available

References

1. Curtis JR, Johnson SR, Anthony DD, et al. American College of Rheumatology Guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5. Arthritis Rheumatol 2023;75:E1–E16.
1. D'Silva KM, Jorge A, Cohen A, et al. COVID‐19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study. Arthritis Rheumatol 2021;73:914–920.
1. Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated With SARS–CoV‐2 and hyperinflammation in pediatric COVID‐19: version 1. Arthritis Rheumatol 2020;72:1791–1805.
1. Gianfrancesco MA, Leykina LA, Izadi Z, et al. Association of race and ethnicity with COVID‐19 outcomes in rheumatic disease: data from the COVID‐19 Global Rheumatology Alliance physician registry. Arthritis Rheumatol 2021;73:374–380.
1. Checco A, Bracciale L, Loreti P, et al. AI‐assisted peer review. Humanit Soc Sci Commun 2021;8:25.